Examining use of telehealth in jails: linking women to community OUD services.
Jails
Opioid use disorder
Telehealth
Women
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
04 Oct 2024
04 Oct 2024
Historique:
received:
29
08
2024
accepted:
27
09
2024
medline:
5
10
2024
pubmed:
5
10
2024
entrez:
4
10
2024
Statut:
epublish
Résumé
Opioid use disorder (OUD) remains a significant health care need for women, particularly those involved in the criminal legal system (CLS). There are no studies to date that focus on the utilization of telehealth as a platform for assessment and linkage to medications to treat opioid use disorder (MOUD) at community re-entry for women, despite the fact that women have unique risk factors that may contribute to opioid relapse in the community. The purpose of this mixed-methods study is to provide an overview of the innovative use of telehealth for linking incarcerated women to community MOUD treatment in the Kentucky-hub of the Justice Community Opioid Innovation Network (JCOIN). This study incorporates qualitative and quantitative data collection with MOUD providers, recovery staff involved in peer navigation services, and women who are incarcerated to understand perceptions of the use of telehealth prior to jail release as a linkage to community services. Findings from this study suggest overall support for the use of telehealth between community MOUD treatment providers and women who are incarcerated using videoconferencing technology. On average, there was very little variation in provider favorable feedback related to clinical engagement or in face-to-face comparability, as well as how telehealth allowed the participant to discuss personal and sensitive issues during the clinical assessment. Study findings suggest benefits associated with the use of telehealth in increasing access to treatment for women with OUD. Jails are critical venues for telehealth interventions because they provide the opportunity to reach women who have been actively using illicit substances, often have advanced-stage substance use disorders which have compromised their health and mental health, and often have not been previously identified as needing treatment. This study was originally registered on 8/23/19, ClinicalTrials.gov, #NCT04069624.
Sections du résumé
BACKGROUND
BACKGROUND
Opioid use disorder (OUD) remains a significant health care need for women, particularly those involved in the criminal legal system (CLS). There are no studies to date that focus on the utilization of telehealth as a platform for assessment and linkage to medications to treat opioid use disorder (MOUD) at community re-entry for women, despite the fact that women have unique risk factors that may contribute to opioid relapse in the community. The purpose of this mixed-methods study is to provide an overview of the innovative use of telehealth for linking incarcerated women to community MOUD treatment in the Kentucky-hub of the Justice Community Opioid Innovation Network (JCOIN).
METHODS
METHODS
This study incorporates qualitative and quantitative data collection with MOUD providers, recovery staff involved in peer navigation services, and women who are incarcerated to understand perceptions of the use of telehealth prior to jail release as a linkage to community services.
RESULTS
RESULTS
Findings from this study suggest overall support for the use of telehealth between community MOUD treatment providers and women who are incarcerated using videoconferencing technology. On average, there was very little variation in provider favorable feedback related to clinical engagement or in face-to-face comparability, as well as how telehealth allowed the participant to discuss personal and sensitive issues during the clinical assessment.
CONCLUSIONS
CONCLUSIONS
Study findings suggest benefits associated with the use of telehealth in increasing access to treatment for women with OUD. Jails are critical venues for telehealth interventions because they provide the opportunity to reach women who have been actively using illicit substances, often have advanced-stage substance use disorders which have compromised their health and mental health, and often have not been previously identified as needing treatment.
TRIAL REGISTRATION
BACKGROUND
This study was originally registered on 8/23/19, ClinicalTrials.gov, #NCT04069624.
Identifiants
pubmed: 39367439
doi: 10.1186/s12905-024-03394-4
pii: 10.1186/s12905-024-03394-4
doi:
Banques de données
ClinicalTrials.gov
['NCT04069624']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
549Subventions
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1DA050069
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerdá M. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022;3:100052. https://doi.org/10.1016/j.dadr.2022.100052 .
doi: 10.1016/j.dadr.2022.100052
pubmed: 35783994
pmcid: 9248998
Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. https://doi.org/10.1016/j.drugpo.2022.103786 .
doi: 10.1016/j.drugpo.2022.103786
pubmed: 35934583
pmcid: 10976290
Alvand S, Amin-Esmaeili M, Poustchi H, Roshandel G, Sadeghi Y, Sharifi V, Kamangar F, Dawsey SM, Freedman ND, Abnet CC, Rahimi-Movaghar A, Malekzadeh R, Etemadi A. Prevalence and determinants of opioid use disorder among long-term opiate users in Golestan Cohort Study. BMC Psychiatry. 2023;23(1):958. https://doi.org/10.1186/s12888-023-05436-x .
doi: 10.1186/s12888-023-05436-x
pubmed: 38129791
pmcid: 10734090
Meyer R, Patel AM, Rattana SK, Quock TP, Mody SH. Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag. 2014;17(6):372–87. https://doi.org/10.1089/pop.2013.0098 .
doi: 10.1089/pop.2013.0098
pubmed: 25075734
pmcid: 4273187
Lipari RN, Hughes A. Trends in heroin use in the United States: 2002 to 2013. 2015 Apr 23. In: The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013–. PMID: 26913325.
D’Orsogna MR, Böttcher L, Chou T. Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the United States. PLOS Glob Public Health. 2023;3(3):e0000769. https://doi.org/10.1371/journal.pgph.0000769 .
doi: 10.1371/journal.pgph.0000769
pubmed: 36962959
pmcid: 10032521
National Institute on Drug Abuse (NIDA). Drug overdose death rates. National Institute on Drug Abuse. 2024. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
Bunting AM, Oser C, Staton M, Knudsen H. Polysubstance use patterns among justice-involved individuals who use opioids. Subst Use Misuse. 2020;55(13):2165–74. https://doi.org/10.1080/10826084.2020.1795683 .
doi: 10.1080/10826084.2020.1795683
pubmed: 32686551
pmcid: 7484418
Boileau-Falardeau M, Contreras G, Gariépy G, Laprise C. Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence. Health Promot Chronic Dis Prev Can. 2022;42(2):47–59. https://doi.org/10.24095/hpcdp.42.2.01 .
doi: 10.24095/hpcdp.42.2.01
pubmed: 35170930
pmcid: 8935897
Carley JA, Oesterle T. Therapeutic approaches to opioid use disorder: what is the current standard of care? Int J Gen Med. 2021;14:2305–11. https://doi.org/10.2147/IJGM.S295461 .
doi: 10.2147/IJGM.S295461
pubmed: 34113160
pmcid: 8184146
Jones CM, Shoff C, Blanco C, Losby JL, Ling SM, Compton WM. Association of receipt of opioid use disorder-related telehealth services and medications for opioid use disorder with fatal drug overdoses among Medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry. 2023;80(5):508–14. https://doi.org/10.1001/jamapsychiatry.2023.0310 .
doi: 10.1001/jamapsychiatry.2023.0310
pubmed: 36988913
pmcid: 10061313
Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O’Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK, Mat Working Group Of CJ-Dats. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus. 2012;33(1):9–18. https://doi.org/10.1080/08897077.2011.611460 .
doi: 10.1080/08897077.2011.611460
pubmed: 22263709
pmcid: 3295578
National Commission on Correctional Health Care (NCCHC). Jail-based medication-assisted treatment: Promising practices, guidelines, and resources for the field. National Commission on Correctional Health; 2018 Oct. https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J. The impact of the opioid crisis on U.S. state prison systems. Health Justice. 2021;9(1):17. https://doi.org/10.1186/s40352-021-00143-9 .
doi: 10.1186/s40352-021-00143-9
pubmed: 34304335
pmcid: 8310396
Ranapurwala SI, Figgatt MC, Remch M, Brown C, Brinkley-Rubinstein L, Rosen DL, Cox ME, Proescholdbell SK. Opioid overdose deaths among formerly incarcerated persons and the General Population: North Carolina, 2000–2018. Am J Public Health. 2022;112(2):300–3. https://doi.org/10.2105/AJPH.2021.306621 .
doi: 10.2105/AJPH.2021.306621
pubmed: 35080937
pmcid: 8802580
Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M, Lowden T, Maddalena N, Metcalfe C, Shaw J, Hickman M. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. 2017;112(8):1408–18. https://doi.org/10.1111/add.13779 .
doi: 10.1111/add.13779
pubmed: 28160345
Benck KN, Seide K, Jones AK, Omori M, Rubinstein LB, Beckwith C, Nowotny KM. United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder. Drug Alcohol Depend. 2023;247:109863. https://doi.org/10.1016/j.drugalcdep.2023.109863 .
doi: 10.1016/j.drugalcdep.2023.109863
pubmed: 37071946
pmcid: 10198943
Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105(1–2):83 – 8. https://doi.org/10.1016/j.drugalcdep.2009.06.015 . Epub 2009 Jul 21. Erratum in: Drug Alcohol Depend. 2011;113(2–3):252. doi: 10.1016/j.drugalcdep.2010.07.002.
Oser CB, Knudsen HK, Staton-Tindall M, Taxman F, Leukefeld C. Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions. Drug Alcohol Depend. 2009;103(Suppl 1):S73–81. https://doi.org/10.1016/j.drugalcdep.2008.11.005 .
doi: 10.1016/j.drugalcdep.2008.11.005
pubmed: 19108957
Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, Latkin C. Availability of medications for the treatment of opioid use disorder among pregnant and Postpartum individuals in US Jails. JAMA Netw Open. 2022;5(1):e2144369. https://doi.org/10.1001/jamanetworkopen.2021.44369 .
doi: 10.1001/jamanetworkopen.2021.44369
pubmed: 35050354
pmcid: 8777564
Cherian T, Lim S, Katyal M, Goldfeld KS, McDonald R, Wiewel E, Khan M, Krawczyk N, Braunstein S, Murphy SM, Jalali A, Jeng PJ, Rosner Z, MacDonald R, Lee JD. Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration. Drug Alcohol Depend. 2024;259:111274. https://doi.org/10.1016/j.drugalcdep.2024.111274 .
doi: 10.1016/j.drugalcdep.2024.111274
pubmed: 38643529
Sharma A, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP. Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil. 2016;7:27–40. https://doi.org/10.2147/SAR.S81602 .
doi: 10.2147/SAR.S81602
pubmed: 27217808
pmcid: 4853155
Williams AR, Barbieri V, Mishlen K, Levin FR, Nunes EV, Mariani JJ, Bisaga A. Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders. Am J Addict. 2017;26(4):319–25. https://doi.org/10.1111/ajad.12527 .
doi: 10.1111/ajad.12527
pubmed: 28328148
pmcid: 5426981
Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, Fox AD. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17. https://doi.org/10.1186/s13722-019-0145-5 .
doi: 10.1186/s13722-019-0145-5
pubmed: 30982468
pmcid: 6463640
Sinkman D, Dorchak G. (2022). Using the Americans with Disabilities Act to reduce overdose deaths. Dep Justice J Fed Law Pract. 2022;70(1):113–128.
Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339–55. https://doi.org/10.1016/j.psc.2010.01.004 .
doi: 10.1016/j.psc.2010.01.004
pubmed: 20385341
pmcid: 3124962
Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 2004;74(3):265–72. https://doi.org/10.1016/j.drugalcdep.2004.02.001 .
doi: 10.1016/j.drugalcdep.2004.02.001
pubmed: 15194204
Mazure CM, Fiellin DA. Women and opioids: something different is happening here. Lancet. 2018;392(10141):9–11. https://doi.org/10.1016/S0140-6736(18)31203-0 .
doi: 10.1016/S0140-6736(18)31203-0
pubmed: 30047402
Springer SA, Biondi BE, Frank C, El-Bassel N. A call to action to combat the opioid epidemic among women. J Addict Med. 2020 Sep/Oct;14(5):364–6. https://doi.org/10.1097/ADM.0000000000000622 .
Staton M, Webster JM, Leukefeld C, Tillson M, Marks K, Oser C, Bush HM, Fanucchi L, Fallin-Bennett A, Garner BR, McCollister K, Johnson S, Winston E. Kentucky women’s Justice Community Opioid Innovation Network (JCOIN): a type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women. J Subst Abuse Treat. 2021;128:108284. https://doi.org/10.1016/j.jsat.2021.108284 .
doi: 10.1016/j.jsat.2021.108284
pubmed: 33455828
pmcid: 8267049
VanHouten JP, Rudd RA, Ballesteros MF, Mack KA. Drug overdose deaths among women aged 30–64 years—United States, 1999–2017. MMWR Morb Mortal Wkly Rep. 2019;68(1):1–5. https://doi.org/10.15585/mmwr.mm6801a1 .
doi: 10.15585/mmwr.mm6801a1
pubmed: 30629574
pmcid: 6342548
Spencer MR, Garnett MF, Miniño AM. Drug overdose deaths in the United Stated, 2002–2022. [online]. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2024 Mar [cited 2024 Jul 22]. NCHS Data Brief No. 491. https://www.cdc.gov/nchs/data/databriefs/db491.pdf
Hartung DM, McCracken CM, Nguyen T, Kempany K, Waddell EN. Fatal and nonfatal opioid overdose risk following release from prison: a retrospective cohort study using linked administrative data. J Subst Use Addict Treat. 2023;147:208971. https://doi.org/10.1016/j.josat.2023.208971 .
doi: 10.1016/j.josat.2023.208971
pubmed: 36821990
pmcid: 10795482
Moore KE, Roberts W, Reid HH, Smith KMZ, Oberleitner LMS, McKee SA. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review. J Subst Abuse Treat. 2019;99:32–43. https://doi.org/10.1016/j.jsat.2018.12.003 .
doi: 10.1016/j.jsat.2018.12.003
pubmed: 30797392
Tian EJ, Venugopalan S, Kumar S, Beard M. The impacts of and outcomes from telehealth delivered in prisons: a systematic review. PLoS ONE. 2021;16(5):e0251840. https://doi.org/10.1371/journal.pone.0251840 .
doi: 10.1371/journal.pone.0251840
pubmed: 33999946
pmcid: 8128277
Rappaport ES, Reynolds HN, Baucom S, Lehman TM. Telehealth support of managed care for a correctional system: the open architecture telehealth model. Telemed J E Health. 2018;24(1):54–60. https://doi.org/10.1089/tmj.2016.0275 .
doi: 10.1089/tmj.2016.0275
pubmed: 28682706
Senanayake B, Wickramasinghe SI, Eriksson L, Smith AC, Edirippulige S. Telemedicine in the correctional setting: a scoping review. J Telemed Telecare. 2018;24(10):669–75. https://doi.org/10.1177/1357633X18800858 .
doi: 10.1177/1357633X18800858
pubmed: 30343655
Staton-Tindall M, Wahler E, Webster JM, Godlaski T, Freeman R, Leukefeld C. Telemedicine-based alcohol services for rural offenders. Psychol Serv. 2012;9(3):298–309. https://doi.org/10.1037/a0026772 .
doi: 10.1037/a0026772
pubmed: 22867122
pmcid: 5024532
Staton-Tindall M, Havens JR, Webster JM, Leukefeld C. METelemedicine: a pilot study with rural alcohol users on community supervision. J Rural Health 2014 Fall;30(4):422–32. https://doi.org/10.1111/jrh.12076
Eibl JK, Gauthier G, Pellegrini D, Daiter J, Varenbut M, Hogenbirk JC, Marsh DC. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug Alcohol Depend. 2017;176:133–8. https://doi.org/10.1016/j.drugalcdep.2017.01.048 .
doi: 10.1016/j.drugalcdep.2017.01.048
pubmed: 28535455
Mahmoud H, Naal H, Whaibeh E, Smith A. Telehealth-based delivery of medication-assisted treatment for opioid use disorder: a critical review of recent developments. Curr Psychiatry Rep. 2022;24(9):375–86. https://doi.org/10.1007/s11920-022-01346-z .
doi: 10.1007/s11920-022-01346-z
pubmed: 35895282
pmcid: 9326140
Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, Dix E, Sullivan C. Treatment outcome comparison between telepsychiatry and face-to-face buprenorphinem medication-assisted treatment for opioid use disorder: a 2-year retrospective data analysis. J Addict Med. 2017 Mar/Apr;11(2):138–44. https://doi.org/10.1097/ADM.0000000000000287 .
Belcher AM, Coble K, Cole TO, Welsh CJ, Whitney A, Weintraub E. Buprenorphine induction in a rural Maryland detention center during COVID-19: implementation and preliminary outcomes of a novel telemedicine treatment program for incarcerated individuals with opioid use disorder. Front Psychiatry. 2021;12:703685. https://doi.org/10.3389/fpsyt.2021.703685 .
doi: 10.3389/fpsyt.2021.703685
pubmed: 34777036
pmcid: 8585441
Guillen AG, Reddy M, Saadat S, Chakravarthy B. Utilization of telehealth solutions for patients with opioid use disorder using buprenorphine: a scoping review. Telemed J E Health. 2022;28(6):761–7. https://doi.org/10.1089/tmj.2021.0308 .
doi: 10.1089/tmj.2021.0308
pubmed: 34714172
Johnson JE, Williams C, Zlotnick C. Development and feasibility of a cell phone-based transitional intervention for women prisoners with comorbid substance use and depression. Prison J. 2015;95(3):330–52. https://doi.org/10.1177/0032885515587466 .
doi: 10.1177/0032885515587466
pubmed: 26508805
pmcid: 4617752
Staton M, Tillson M, Levi MM, Webster M, Oser C, Leukefeld C. Screening incarcerated women for opioid use disorder. J Drug Issues. 2024;54(1):57–73. https://doi.org/10.1177/00220426231151595 .
doi: 10.1177/00220426231151595
pubmed: 38046434
Tillson M, Fallin-Bennett A, Staton M. Providing peer navigation services to women with a history of opioid misuse pre- and post-release from jail: a program description. J Clin Transl Sci. 2022;6(1):e106. https://doi.org/10.1017/cts.2022.441 .
doi: 10.1017/cts.2022.441
pubmed: 36128341
pmcid: 9453575
Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1):108. https://doi.org/10.1186/s13012-017-0635-3 .
doi: 10.1186/s13012-017-0635-3
pubmed: 28851459
pmcid: 5576104
United States Department of Agriculture, Economic Research Service. Rural-uban continuum codes. United States Department of Agriculture. 2023. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/
Appalachian Regional Commission. Subregions in Appalachia. Appalachian Regional Commission. 2021. https://www.arc.gov/map/subregions-in-appalachia/
American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders. 5th edition. Arlington, VA: American Psychiatric Association. 2013. https://doi.org/10.1176/appi.books.9780890425596
National Institute on Drug Abuse (NIDA). NIDA-Modified Alcohol, Smoking, and Substance Involvement Screening Test. National Institute on Drug Abuse; 2009. https://datashare.nida.nih.gov/instrument/nida-modified-alcohol-smoking-and-substance-involvement-screening-test
Dennis ML. Global Appraisal of Individual needs (GAIN). Chestnut Health Systems; 1998. https://gaincc.org/instruments/
Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study. Am J Prev Med. 1998;14(4):245–58. https://doi.org/10.1016/s0749-3797(98)00017-8 .
doi: 10.1016/s0749-3797(98)00017-8
pubmed: 9635069
Annett J, Tillson M, Walker M, Webster JM, Staton M. Adverse childhood experiences and mental health among incarcerated women: self-esteem as a mediating mechanism. Child Abuse Negl. 2023;146:106486. https://doi.org/10.1016/j.chiabu.2023.106486 .
doi: 10.1016/j.chiabu.2023.106486
pubmed: 37788588
Fife ST, Gossner JD. (2024). Deductive qualitative analysis: Evaluating, expanding, and refining theory. Int J Qual Methods. 2024;23. https://doi.org/10.1177/16094069241244856
Cantor AG, Nelson HD, Pappas M, Atchison C, Hatch B, Huguet N, Flynn B, McDonagh M. Telehealth for women’s preventive services for reproductive health and intimate partner violence: a comparative effectiveness review. J Gen Intern Med. 2023;38(7):1735–43. https://doi.org/10.1007/s11606-023-08033-6 .
doi: 10.1007/s11606-023-08033-6
pubmed: 36650334
pmcid: 9845023
DeNicola N, Grossman D, Marko K, Sonalkar S, Butler Tobah YS, Ganju N, Witkop CT, Henderson JT, Butler JL, Lowery C. Telehealth interventions to improve obstetric and gynecologic health outcomes: a systematic review. Obstet Gynecol. 2020;135(2):371–82. https://doi.org/10.1097/AOG.0000000000003646 .
doi: 10.1097/AOG.0000000000003646
pubmed: 31977782
pmcid: 7012339
Goldstein KM, Zullig LL, Dedert EA, Alishahi Tabriz A, Brearly TW, Raitz G, Sata SS, Whited JD, Bosworth HB, Gordon AM, Nagi A, Williams JW Jr, Gierisch JM. Telehealth interventions designed for women: an evidence map. J Gen Intern Med. 2018;33(12):2191–200. https://doi.org/10.1007/s11606-018-4655-8 .
doi: 10.1007/s11606-018-4655-8
pubmed: 30284173
pmcid: 6258612
Zhao L, Chen J, Lan L, Deng N, Liao Y, Yue L, Chen I, Wen SW, Xie RH. Effectiveness of telehealth interventions for women with postpartum depression: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2021;9(10):e32544. https://doi.org/10.2196/32544 .
doi: 10.2196/32544
pubmed: 34617909
pmcid: 8532017
Bashshur RL, Reardon TG, Shannon GW. Telemedicine: a new health care delivery system. Annu Rev Public Health. 2000;21:613–37. https://doi.org/10.1146/annurev.publhealth.21.1.613 .
doi: 10.1146/annurev.publhealth.21.1.613
pubmed: 10884967
Myers TC, Swan-Kremeier L, Wonderlich S, Lancaster K, Mitchell JE. The use of alternative delivery systems and new technologies in the treatment of patients with eating disorders. Int J Eat Disord. 2004;36(2):123–43. https://doi.org/10.1002/eat.20032 .
doi: 10.1002/eat.20032
pubmed: 15282683
Shore JH, Manson SM. A developmental model for rural telepsychiatry. Psychiatr Serv. 2005;56(8):976–80. https://doi.org/10.1176/appi.ps.56.8.976 .
doi: 10.1176/appi.ps.56.8.976
pubmed: 16088015
Shore JH, Brooks E, Savin DM, Manson SM, Libby AM. An economic evaluation of telehealth data collection with rural populations. Psychiatr Serv. 2007;58(6):830–5. https://doi.org/10.1176/ps.2007.58.6.830 .
doi: 10.1176/ps.2007.58.6.830
pubmed: 17535944
Boyd J, Carter M, Baus A. Access to MAT: Participants’ experiences with transportation, non-emergency transportation, and telehealth. J Prim Care Community Health 2024 Jan-Dec;15:21501319241233198. https://doi.org/10.1177/21501319241233198
Oser CB, Rockett M, Otero S, Batty E, Booty M, Gressick R, Staton M, Knudsen HK. Rural and urban clinician views on COVID-19’s impact on substance use treatment for individuals on community supervision in Kentucky. Health Justice. 2024;12(1):12. https://doi.org/10.1186/s40352-024-00266-9 .
doi: 10.1186/s40352-024-00266-9
pubmed: 38530619
pmcid: 10964696
Manfredi L, Shupe J, Batki SL. Rural jail telepsychiatry: a pilot feasibility study. Telemed J E Health. 2005;11(5):574–7. https://doi.org/10.1089/tmj.2005.11.574 .
doi: 10.1089/tmj.2005.11.574
pubmed: 16250821
Young JD, Badowski ME, Telehealth. Increasing Access to High Quality Care by expanding the role of technology in Correctional Medicine. J Clin Med. 2017;6(2):20. 10.3390/.
doi: 10.3390/jcm6020020
pubmed: 28208807
pmcid: 5332924
Deslich SA, Thistlethwaite T, Coustasse A. Telepsychiatry in correctional facilities: using technology to improve access and decrease costs of mental health care in underserved populations. Perm J. 2013 Summer;17(3):80–6. https://doi.org/10.7812/TPP/12-123 .
Tormohlen KN, Eisenberg MD, Fingerhood MI, Yu J, McCourt AD, Stuart EA, Rutkow L, Quintero L, White SA, McGinty EE. Trends in opioid use disorder outpatient treatment and telehealth utilization before and during the COVID-19 pandemic. Psychiatr Serv. 2024;75(1):72–5. https://doi.org/10.1176/appi.ps.20230102 .
doi: 10.1176/appi.ps.20230102
pubmed: 37461819
Duncan A, Sanders N, Schiff M, Winkelman TNA. Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic. J Subst Abuse Treat. 2021;121:108161. https://doi.org/10.1016/j.jsat.2020.108161 . Epub 2020 Oct 8. PMID: 33371945; PMCID: PMC7543710.
doi: 10.1016/j.jsat.2020.108161
pubmed: 33371945
Zaylor C. Clinical outcomes in telepsychiatry. J Telemed Telecare. 1999;5(Suppl 1):S59–60. https://doi.org/10.1258/1357633991932577 .
doi: 10.1258/1357633991932577
pubmed: 10534844
Nelson EL, Barnard M, Cain S. Treating childhood depression over videoconferencing. Telemed J E Health 2003 Spring;9(1):49–55. https://doi.org/10.1089/153056203763317648
Oser CB, Harp KL. Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance. J Subst Abuse Treat. 2015;48(1):77–84. https://doi.org/10.1016/j.jsat.2014.08.002 .
doi: 10.1016/j.jsat.2014.08.002
pubmed: 25200740
Staton M, Cramer J, Walker R, Snell-Rood C, Kheibari A. The importance of shared language in rural behavioral health interventions: an exploratory linguistic analysis. Rural Ment Health. 2019;43(4):138–49. https://doi.org/10.1037/rmh0000117 .
doi: 10.1037/rmh0000117
pubmed: 33312331
pmcid: 7731584
Staton M, Strickland JC, Webster JM, Leukefeld C, Oser C, Pike E. HIV prevention in rural Appalachian jails: implications for re-entry risk reduction among women who use drugs. AIDS Behav. 2018;22(12):4009–18. https://doi.org/10.1007/s10461-018-2209-z .
doi: 10.1007/s10461-018-2209-z
pubmed: 29959722
pmcid: 6475200